Email This Article

Plans for New Cancer Drug Help Raise Idec's Estimates
By Adam Feuerstein
03/05/02 - 12:26 PM EST
The company will soon roll out Zevalin with very healthy margins.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,452.00 1,107.93 2,201.05 36.03
Oil *
72.08
DOWN
49.05
DOWN
6.18
DOWN
11.05
UP
0.57
10 Yr
3.60%
SPDR Gold
110.21
-0.47%
-0.55%
-0.50%
+1.61%
Data delayed 20 minutes

Brokerage Partners